Abstract |
The neuropeptide substance P (SP), by stimulating tachykinin NK1 receptors (NK1R), triggers a number of biological responses in human glioma cells which are potentially relevant for tumour growth. First, radioligand binding studies demonstrated the presence of tachykinin NK1R on SNB-19, DBTRG-05 MG and U373 MG, but not on U138 MG and MOG-G-GCM human glioma cell lines. Second, application of SP or neurokinin A (NKA) to NK1R+ glioma cell lines increased the secretion of interleukin 6 (IL-6) and potentiated IL-6 secretion induced by IL-1beta. SP also up-regulated the release of transforming growth factor beta1 (TGF-beta1) by the U373 MG glioma cell line. Third, SP induced new DNA synthesis and enhanced the proliferation rate of NK1R+, but not of NK1R- glioma cell lines. Also, NKA stimulated the proliferation and cytokine secretion in NK1R+ glioma cell lines. All the stimulant effects of SP/NKA on NK1R+ glioma cell lines were completely blocked by a specific tachykinin NK1R antagonist, MEN 11467. These data support the potential use of tachykinin NK1R antagonist for controlling the proliferative rate of human gliomas.
|
Authors | C Palma, F Nardelli, S Manzini, C A Maggi |
Journal | British journal of cancer
(Br J Cancer)
Vol. 79
Issue 2
Pg. 236-43
(Jan 1999)
ISSN: 0007-0920 [Print] England |
PMID | 9888463
(Publication Type: Journal Article)
|
Chemical References |
- DNA, Neoplasm
- Interleukin-6
- Neoplasm Proteins
- Neurokinin-1 Receptor Antagonists
- Receptors, Neurokinin-1
- Transforming Growth Factor beta
- Interleukin-10
- Substance P
- Neurokinin A
|
Topics |
- Cell Division
(drug effects)
- DNA, Neoplasm
(biosynthesis)
- Glioma
(metabolism, pathology)
- Humans
- Interleukin-10
(metabolism)
- Interleukin-6
(metabolism)
- Neoplasm Proteins
(drug effects, metabolism)
- Neurokinin A
(pharmacology)
- Neurokinin-1 Receptor Antagonists
- Receptors, Neurokinin-1
(drug effects, metabolism)
- Substance P
(antagonists & inhibitors, metabolism, pharmacology)
- Transforming Growth Factor beta
(metabolism)
- Tumor Cells, Cultured
(drug effects)
|